Claret Asset Management Corp Lannett CO Inc Transaction History

Claret Asset Management Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$5.58 - $14.47 $646,593 - $1.68 Million	-115,877 Closed	0 $0
Q2 2019 Jul 24, 2019	SELL	$5.22 - $9.08 $103,658 - $180,310	-19,858 Reduced 14.63%	115,877 $702,000
Q1 2019 Apr 29, 2019	SELL	$5.35 - $9.82 $287,048 - $526,882	-53,654 Reduced 28.33%	135,735 $1.07 Million
Q4 2018 Feb 07, 2019	SELL	$3.43 - $6.19 $734,129 - $1.32 Million	-214,032 Reduced 53.05%	189,389 $939,000
Q3 2018 Oct 30, 2018	SELL	$4.75 - $14.5 $37,240 - $113,680	-7,840 Reduced 1.91%	403,421 $1.92 Million
Q2 2018 Aug 13, 2018	BUY	$13.3 - $17.45 $451,229 - $592,026	33,927 Added 8.99%	411,261 $5.59 Million
Q1 2018 May 08, 2018	SELL	$14.7 - $24.95 $152,630 - $259,055	-10,383 Reduced 2.68%	377,334 $6.06 Million
Q4 2017 Mar 27, 2018	BUY	$19.9 - $29.25 $7.72 Million - $11.3 Million	387,717	387,717 $9 Million

Ticker LCI
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,960,000
Market Cap $1.29M
Description
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...

Get notified when there are updates to the investment portfolio of Claret Asset Management Corp, based on Form 13F filings with the SEC.

Stay updated on Claret Asset Management Corp with notifications on news.